AIM IMMUNOTECH INC. Exchange Fees
AIM IMMUNOTECH INC. (AIM) reported Exchange Fees of $1.90 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ExchangeFees · last filed 2026-08-07
- AIM IMMUNOTECH INC. exchange fees for the quarter ending 2025-09-30 was $1.90M.
| Period end | Exchange Fees 3 month | Exchange Fees 3 month as first filed |
|---|---|---|
| 2025-09-30 | $1.90M 10-Q · filed 2026-08-07 | $1.88M 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |